MeSH term
Frequency | Condition_Probility | Aged | 8 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 16 | 0.0 |
Humans | 34 | 0.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Male | 17 | 0.0 |
Middle Aged | 6 | 0.0 |
*Polymorphism, Genetic | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Apolipoproteins C/*genetics/metabolism | 3 | 42.0 |
Apolipoproteins E/genetics | 5 | 1.0 |
Gene Frequency/*genetics | 2 | 1.0 |
Genotype | 7 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Alleles | 4 | 0.0 |
Apolipoproteins C/*genetics | 13 | 14.0 |
Apolipoproteins E/*genetics | 7 | 0.0 |
Comparative Study | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Linkage Disequilibrium | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Animals | 15 | 0.0 |
Apolipoproteins C/*genetics/physiology | 2 | 66.0 |
Cholesterol/blood | 5 | 0.0 |
Fatty Acids/metabolism | 2 | 1.0 |
Insulin/blood | 2 | 0.0 |
Insulin Resistance/*genetics | 2 | 2.0 |
Mice | 14 | 0.0 |
Mice, Transgenic | 10 | 0.0 |
Triglycerides/blood | 5 | 0.0 |
Apolipoproteins C/genetics | 4 | 11.0 |
Phenotype | 3 | 0.0 |
Gene Expression | 4 | 0.0 |
Insulin/*blood | 2 | 1.0 |
Liver/metabolism | 3 | 0.0 |
Adult | 4 | 0.0 |
Variation (Genetics) | 3 | 0.0 |
Adolescent | 3 | 0.0 |
Pedigree | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Genetic Markers | 5 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Receptors, LDL/*genetics | 2 | 1.0 |
Cell Line | 2 | 0.0 |
*Multigene Family | 3 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Introns | 2 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Cosmids | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
Genes, Structural | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 19 | 2 | 1.0 |
Hybrid Cells | 3 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Myotonic Dystrophy/*genetics | 3 | 4.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Apolipoproteins/*genetics | 3 | 4.0 |
*Polymorphism, Restriction Fragment Length | 3 | 0.0 |
*Chromosomes, Human, Pair 19 | 4 | 1.0 |
*Deoxyribonucleases, Type II Site-Specific | 2 | 3.0 |
*Chromosome Mapping | 2 | 0.0 |
*Genes, Structural | 2 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
*Chromosomes, Human, 19-20 | 2 | 9.0 |
